Stocktoria
Solvay SA SOLB.BR
BE · Euronext Brussels · XBRU · stock · Basic Materials · website
Solvay SA financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €4.7B | €5.1B | €6.0B | €8.0B |
| Gross profit | €1.0B | €1.1B | €1.4B | €1.4B |
| R&D expense | €23.0M | €34.0M | €47.0M | €46.0M |
| SG&A expense | €489.0M | €419.0M | €526.0M | €565.0M |
| Operating income | €476.0M | €651.0M | €819.0M | €802.0M |
| Interest expense | €125.0M | €123.0M | €133.0M | €54.0M |
| Income tax | €120.0M | €87.0M | €208.0M | €228.0M |
| Net income | €30.0M | €223.0M | €2.1B | €1.9B |
| EPS (diluted) | €0.28 | €2.10 | €19.85 | €18.30 |
| Operating cash flow | €682.0M | €615.0M | €1.9B | €2.0B |
| Free cash flow | €462.0M | €330.0M | €847.0M | €1.1B |
| Cash & equivalents | €536.0M | €539.0M | €584.0M | €932.0M |
| Inventory | €587.0M | €623.0M | €642.0M | €2.1B |
| Total assets | €6.2B | €6.7B | €7.0B | €20.7B |
| Total liabilities | €5.1B | €5.3B | €5.7B | €10.0B |
| Shareholders' equity | €1.0B | €1.3B | €1.3B | €10.6B |
Growth · year-over-year · Revenue CAGR -15.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -7.5% | -14.9% | -24.5% | — |
| Net income growth | -86.5% | -89.3% | +9.9% | — |
| EPS growth | -86.7% | -89.4% | +8.5% | — |
| Free cash flow growth | +40.0% | -61.0% | -22.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · BE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.